Phosphodiesterase-4 Modulation as a Potential Therapeutic for Cognitive Loss in Pathological and Non-Pathological Aging: Possibilities and Pitfalls

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|3|291-302

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.3, 2015-01, pp. : 291-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging

By  

Current Medicinal Chemistry, Vol. 17, Iss. 34, 2010-12 ,pp. : 4150-4165

Bentham Science Publishers

Access to resources Recommend Favorite

The Loss of Pathological Specimens: Incidence and Causes

By SANDBANK SHARON   KLEIN DORON   WESTREICH MELVYN   SHALOM AVSHALOM  

Dermatologic Surgery, Vol. 36, Iss. 7, 2010-07 ,pp. : 1084-1086

Elsevier

Access to resources Recommend Favorite

Editorial (Thematic Issue: Purinergic P2X Receptors: Physiological and Pathological Roles and Potential as Therapeutic Targets)

By  

Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. : 782-782

Bentham Science Publishers

Access to resources Recommend Favorite

IL-4 and IL-13: Their Pathological Roles in Allergic Diseases and their Potential in Developing New Therapies-Update

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 2, 2005-04 ,pp. : 149-152

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase-4 as a potential drug target

By Zhang Kam YJ   Ibrahim Prabha N   Gillette Sam   Bollag Gideon  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1283-1305

Informa Healthcare

Access to resources Recommend Favorite